Finally, high abundance of KCa3.1 mRNA in glioblastoma resection specimens has been proposed to associate with poor survival times of glioblastoma patients in both the REMBRANDT [14] and TCGA patient cohorts [17], even though this type of analysis suffers from structural weaknesses (as discussed in [18]). The gene discussed is KCNN4; the disease is glioblastoma.